James Mazzo takes on AdvaMed chair
This article was originally published in RAJ Devices
US medical device industry association AdvaMed has appointed James Mazzo as the new chair of its board of directors. Mr Mazzo is president of Abbott Medical Optics; he will serve a two-year term, succeeding Edwards Lifesciences’ chairman and chief executive Michael Mussallem, who has chaired AdvaMed since 2008.
You may also be interested in...
The withdrawal of the EU filing for abicipar pegol will fuel speculation that Allergan parent AbbVie is indeed ditching the potential treatment for wet AMD. US regulators have already said they won't approve the drug.
There is speculation that it is the end of the road for abicipar pegol but Allergan has declined to say whether this is the case for the product that has been in development for wet AMD.